WSJ: are #coronavirus vaccines riskier than advertised?

Wall Street Journal opinion: “not a single published study has demonstrated that patients with a prior infection benefit from Covid-19 vaccination. That this isn’t readily acknowledged by the CDC or Anthony Fauci is an indication of how deeply entangled pandemic politics is in science.”

WSJ Opinion: Are Covid Vaccines Riskier Than Advertised?

 

Israel: 50% vaccine breakthrough for #coronavirus cases in the last month

 

 

Photo by CDC on Unsplash

 

 

So what is Plan B if the vaccines fail?

14th June 2021: We’ve spent two days scouring the internet looking for Plan B for what happens in the event of complete Covid-19 vaccine failure. So what does happen if the vaccines fail? Here is what we have found so far:

Actually, we found no results. It seems that no one is even asking the question. Perhaps it’s time to start that conversation?

 

Global Covid-19 Map courtesy of John Hopkins University

 


 

** UPDATE 31ST JULY 2021 **  Finally, the UK government takes a peek out of the front screen to see what is oncoming rather than checking the rear-view mirror to look at the pile-up that has just occurred.

*Warning*  The report contains plenty of dire predictions but proposes no solutions whatsoever.

UK SAGE Bombshell Report: The Long Term Evolution of Sars-CoV-2

 


 

** UPDATE 15th AUGUST 2021 ** 

“UK Ministers are being pressed to reveal what contingency plans are in place to deal with a future Covid variant that evades current vaccines, amid warnings from scientific advisers that such an outcome could set the battle against the pandemic back a year or more.”  

Guardian article

 


 

** UPDATE 27th AUGUST 2021 **

If you have two hours to waste, you could spend it reading this new European view on the future of Sars-CoV-2:

A look into the future of the COVID-19 pandemic in Europe: an expert consultation

In our opinion, this article is by far the poorest attempt yet to predict the future course of the pandemic, relying largely on outdated information and stale groupthink. For example:

What can be expected in the autumn and winter of 2021 depends substantially on what happens in the summer; specifically, the success of vaccination programs both in Europe and worldwide, and the emergence and spread of (new) VOCs. Compared to the summer, autumn and winter bring the additional complication of unfavorable seasonal effects. The seasonality of coronaviruses is expected to increase infections in the autumn and winter months…..”

It’s a 0/10 from us.

 


 

** UPDATE 14TH SEPTEMBER 2021 **

The UK has another stab at Plan B:

 

The UK announces its winter Covid plans

 

Er, yeah, I guess we’ll keep searching…

 


 

 

USA: #coronavirus vaccine breakthrough infections are potentially contagious

Researchers reported that among 20 fully-vaccinated healthcare workers with vaccine breakthrough COVID-19 cases, all were infected with coronavirus variants. An earlier study had linked breakthrough infections with low viral loads, suggesting low transmission risks, but “we found many samples in our breakthrough cohort with high viral load,” said coauthor Pavitra Roychoudhury of the University of Washington. CONTAGIOUS: “Our work suggests that not all breakthrough infections are at low risk of initiating transmission and, if they did, these infections could lead to the continued spread of variants of concern, particularly in areas with low vaccination rates.”

The CDC has genetic data for virus samples from 555 vaccine breakthrough infections. Mutated variants of the coronavirus, including those first seen in the UK and South Africa, accounted for 64% of the breakthroughs.

Vancouver Sun report

Medrxix preprint – Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State

VICTIMS: “Vaccine-Induced Covid-19 Mimicry Syndrome”

FT: “the vaccines send the DNA gene sequences of the spike protein into the cell … Once inside the cell nucleus, certain parts of the spike protein splice, or split apart

During the last months many countries have started the immunization of millions of people by using vector-based vaccines. Unfortunately, severe side effects became overt during these vaccination campaigns: cerebral venous sinus thromboses (CVST), absolutely rare under normal life conditions, were found as a severe side effect that occured 4-14 days after first vaccinations. Besides CVST, Splanchnic Vein Thrombosis (SVT) was also observed. This type of adverse event has not been observed in the clinical studies of AstraZeneca, and therefore led immediately to a halt in vaccinations in several european countries.

These events were mostly associated with thrombocytopenia, and thus, similar to the well-known Heparin-induced thrombo­cytopenia (HIT). Meanwhile, scientists have proposed a mechanism to explain this vaccine-induced thrombocytopenia. However, they do not provide a satisfactory explanation for the late thromboembolic events. Here, we present data that may explain these severe side effects which have been attributed to adenoviral vaccines.

According to our results, transcription of wildtype and codon-optimized Spike open reading frames enables alternative splice events that lead to C-terminal truncated, soluble Spike protein variants. These soluble Spike variants may initiate severe side effects when binding to ACE2-expressing endothelial cells in blood vessels. In analogy to the thromboembolic events caused by Spike protein encoded by the SARS-CoV-2 virus, we termed the underlying disease mechanism the “Vaccine-Induced Covid-19 Mimicry” syndrome (VIC19M syndrome).

Researchgate paper “Vaccine-Induced Covid-19 Mimicry Syndrome: Splice reactions within the SARS-CoV-2 Spike open reading frame result in Spike protein variants that may cause thromboembolic events in patients immunized with vector-based vaccines”.

FT Article  “Scientists claim to have solved Covid vaccine blood-clot puzzle”

 

 

Image by v-a-n-3-ss-a from Pixabay

The highest ever #coronavirus daily case rates recorded on Planet Earth – and it’s not India or Brazil

The highest ever daily country case figure for coronavirus on Planet Earth was recorded in The Seychelles in May 2021. The Seychelles daily case figure, adjusted for population, reached an astonishing 4,083 cases per million. 

What is also surprising is that many of the countries on the list with the highest daily case rates also have excellent vaccination rates (see below). The Seychelles, for example, has vaccinated more than 60% of its population.

The reasons behind some of the high daily case numbers are given in articles we have previously published and have linked to below.

 

Seychelles: a population of 100,000 that has 900 #coronavirus vaccine breakthrough cases

Maldives: 60% positivity rate in Greater Male – “High chance of new #coronavirus variant”

Uruguay: over 1,000 daily new confirmed COVID-19 cases per million people

Sweden’s daily #coronavirus case rate far higher than Brazil or India

 

Charts courtesy of OurWorldinData.org

India: Covaxin and Covishield vaccines invoke 50% fewer antibodies against B.1.617 #coronavirus variant

Scientists at the Indian National Institute of Virology (NIV), Pune, have found that both Covaxin and Covishield produce half as many antibodies against the B.1.617 variant of the novel coronavirus as against the ‘original’ B.1 variant.

The scientists conducted their studies with blood sera (plural of serum, the fluid part of the blood) obtained from people who had received either two doses of *Covaxin or two doses of *Covishield. They were motivated by the need to understand how the vaccines’ efficacies varied against infections due to newer strains of the virus. The B.1.617 variant – made up of three sub-lineages – is accounting for more cases in India. The UK recently elevated the B.1.617.2 sub-lineage as a ‘variant of concern’.

TheWire.in report

*Covaxin was developed by Indian pharmaceutical company Bharat Biotech in collaboration with the Indian Council of Medical Research

*Covishield is India’s version of the Oxford-AstraZeneca vaccine manufactured in Pune by the Serum Institute of India

 

Charty courtesy of OurWorldINData.org